Streptococcus pneumoniae serotype 6A capsular antigen diphtheria CRM197 protein conjugate vaccine Uses, Dosage, Side Effects and more
Streptococcus pneumoniae serotype 6A capsular antigen diphtheria CRM197 protein conjugate vaccine is a sterile vaccine that contains saccharides of the capsular antigens of Streptococcus pneumoniae serotype 6a individually conjugated to the CRM197 protein, a nontoxic variant of diphtheria toxin isolated from cultures of Corynebacterium diphtheriae strain C7 (β197). The saccharides in the vaccine are prepared from purified polysaccharides that are chemically activated then conjugated to the protein carrier CRM197 to form the glycoconjugate.
| Attribute | Details |
|---|---|
| Trade Name | Streptococcus pneumoniae serotype 6A capsular antigen diphtheria CRM197 protein conjugate vaccine |
| Generic | Streptococcus pneumoniae type 6A capsular polysaccharide diphtheria CRM197 protein conjugate antigen |
| Streptococcus pneumoniae type 6A capsular polysaccharide diphtheria CRM197 protein conjugate antigen Other Names | Streptococcus pneumoniae serotype 6A capsular antigen diphtheria CRM197 protein conjugate vaccine |
| Type | |
| Groups | Approved, Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
